Novavax is a partial protein based or subprotein based vaccine. We will discuss following topics in this session:
1. Why is Novavax vaccine different from other vaccines?
2. How is the Novavax partial-protein vaccine manufactured?
3. What adjuvant is used in building this vaccine?
4. Trial results from the UK phase III trial, and South Africa phase II trials of Novavax.
5. Will the vaccine help against the South African variant?
Mobeen Syed is the CEO of DrBeen Corp, a modern online medical education marketplace. Mobeen is a medical doctor and a software engineer. He graduated from the prestigious King Edward Medical University Lahore. He has been teaching medicine since 1994. Mobeen is also a software engineer and engineering leader. In this role, Mobeen has run teams consisting of hundreds of engineers and millions of dollars of budgets. Mobeen loves music, teaching, and doing business. He lives in Cupertino CA.